Worldwide Generic Drug Industry Discussed in New MarketLine Study Recently Published at

01 Oct 2012 • by Natalie Aster

LONDON – The global generics market is projected to grow from USD 187.2 billion in 2011 to hit a value of USD 273.6 billion by the end of 2016, up 46.1% over the year 2011. In volume terms, the global generics market is expected to increase by 13.5% from 2011 to account for 85.1% of total pharma volume by 2016. Geographically, the Americas account for 46% of the global generics market value.

New research study “Generics: Global Industry Guide” developed by MarketLine presents top-level data and in-depth analysis on the generics industry at a global, regional (European and the Asia-Pacific) and country level (France, Germany, Japan, the UK and the US). It features executive summary and granular data on market size (value & volume) and segmentation, textual analysis of the industry's prospects, competitive landscape along with elaborate profiles of the top companies operating in the marketplace. Additionally, a five-year forecast of the generics industry is also provided.

Report Details:

Generics: Global Industry Guide
Published: August, 2012
Pages: 253
Price: US$ 1.495,00

More new research studies by the publisher can be found at MarketLine page.


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970